Lucid Diagnostics Inc. (LUCD) Misses Q4 EPS by 1c

Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q4 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.39 million.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• 22nd Century Group files prospectus for warrant share resale
• Circle board member resigns after nearly 13 years of service